UCB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
15 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
November 1, 2012 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
Get the moves on UCB by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 19, 2026 | Citadel Advisors LLC | 0.50% | |
| February 9, 2024 | Qube Research & Technilogies Limited | 0.51% | |
| April 3, 2014 | Scopia Capital Management LLC | 0.68% | October 16, 2014 |
| February 21, 2014 | BNP Paribas SA | 0.61% | March 3, 2014 |
| February 13, 2014 | BNP Paribas SA | 0.56% | February 21, 2014 |
| January 21, 2014 | Scopia Capital Management LLC | 0.70% | April 3, 2014 |
| January 3, 2014 | Scopia Capital Management LLC | 0.83% | January 21, 2014 |
| November 26, 2013 | AKO Capital LLP | 0.50% | March 6, 2014 |
| July 31, 2013 | Scopia Capital Management LLC | 0.61% | January 3, 2014 |
| July 1, 2013 | AKO Capital LLP | 0.51% | August 1, 2013 |
| June 10, 2013 | Scopia Capital Management LLC | 0.58% | July 31, 2013 |
| March 19, 2013 | Scopia Capital Management LLC | 0.78% | June 10, 2013 |
| January 2, 2013 | Scopia Capital Management LLC | 0.81% | March 19, 2013 |
| November 8, 2012 | Scopia Capital Management LLC | 0.79% | January 2, 2013 |
| November 1, 2012 | Scopia Capital Management LLC | 0.80% | November 8, 2012 |
Download 15 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Belgium
- Solvay 1.39% of the capital sold short
- Umicore 1.20% of the capital sold short
- EVS 0.89% of the capital sold short
- D'Ieteren Group 0.79% of the capital sold short
- Syensqo 0.79% of the capital sold short
- Azelis 0.69% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- Montea 0.60% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, UCB, source FSMA, data as at August 19, 2026, https://www.quivad.com/action/ucb